Flanagan Glenda J

SEC Form 4 insider trading activity

Flanagan Glenda J has filed 5 SEC Form 4 filings (5 transaction rows) across 2 companies, including VITL, CACC, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.

On the most recent filing, Flanagan Glenda J is listed as Director at Vital Farms, Inc. Inside the rolling window, Flanagan Glenda J reported 1 open-market purchase totaling $51K in VITL and no open-market sales.

Companies traded

Other insiders at VITL

Insider Buying

$51K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

2

in the rolling window

Source
VITL
Flanagan Glenda J
Purchase$51KMay 21SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Flanagan Glenda J made?

Flanagan Glenda J has filed 5 SEC Form 4 filings (5 transaction rows) across 2 companies, including VITL, CACC since 2025.

Which companies does Flanagan Glenda J trade?

Flanagan Glenda J has filed SEC Form 4 disclosures for 2 companies, including VITL, CACC.

When was Flanagan Glenda J's most recent SEC Form 4 filing?

Flanagan Glenda J's most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.

What is Flanagan Glenda J's total buy and sell value in the current window?

Inside the rolling retention window, Flanagan Glenda J bought $51K and sold $0 based on SEC Form 4 filings.

What was Flanagan Glenda J's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 6,100 VITL shares on 2026-05-18, worth $51K, per SEC Form 4 filings.